Manish K Chourasia Selected Research

asolectin

12/2022

Development of asolectin-based liposomal formulation for controlled and targeted delivery of erlotinib as a model drug for EGFR monotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manish K Chourasia Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 01/2016
7	Breast Neoplasms (Breast Cancer) 04/2019 - 12/2014
7	Visceral Leishmaniasis (Kala Azar) 12/2017 - 01/2011
6	Leishmaniasis 11/2016 - 12/2013
4	Hemolysis 12/2022 - 08/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 09/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022
1	Postmenopausal Osteoporosis 10/2021
1	Osteoporosis 10/2021
1	Body Weight (Weight, Body) 04/2019
1	Inflammation (Inflammations) 08/2017
1	Endometrial Neoplasms (Endometrial Cancer) 08/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Infections 08/2015

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 12/2022 - 09/2006
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2011
6	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2017 - 04/2013
5	ChitosanIBA 12/2017 - 01/2011
3	Biological ProductsIBA 04/2019 - 12/2013
3	MicellesIBA 12/2017 - 04/2016
3	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2017 - 04/2013
3	NanocapsulesIBA 08/2015 - 04/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 12/2014
2	Polysaccharides (Glycans)IBA 02/2019 - 09/2017
2	CurcuminIBA 08/2017 - 04/2016
2	Docetaxel (Taxotere)FDA Link 01/2016 - 10/2015
1	ErbB Receptors (EGF Receptor)IBA 12/2022
1	SolutionsIBA 12/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022
1	asolectinIBA 12/2022
1	Ether (Diethyl Ether)IBA 12/2022
1	Levofloxacin (Levaquin)FDA Link 01/2022
1	CyclodextrinsIBA 10/2021
1	ResveratrolIBA 10/2021
1	AntioxidantsIBA 10/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2020
1	tocophersolanIBA 11/2020
1	TubulinIBA 04/2019
1	carbazoleIBA 04/2019
1	fucoidanIBA 02/2019
1	SuspensionsIBA 12/2017
1	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 09/2017
1	PolyethyleneimineIBA 09/2017
1	ZymosanIBA 09/2017
1	CytokinesIBA 08/2017
1	SurvivinIBA 08/2017
1	RhodaminesIBA 08/2017
1	Taxoids (Taxanes)IBA 05/2017
1	Gemcitabine FDA Link 01/2017
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	Biotin (Vitamin H)FDA Link 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	AerosolsIBA 01/2017
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 01/2017
1	biotin receptorIBA 01/2017
1	calcium phosphateIBA 11/2016
1	Linoleic Acid (Linoleate)IBA 04/2016
1	Ethylene Glycol (Monoethylene Glycol)IBA 04/2016
1	monomethoxypolyethylene glycol (MPEG)IBA 04/2016
1	Conjugated Linoleic AcidsIBA 04/2016
1	Poloxamer (Poloxamer 407)IBA 10/2015
1	Mannose (D-Mannose)IBA 08/2015
1	ChondroitinIBA 08/2015
1	Capecitabine (Xeloda)FDA Link 01/2015
1	LactoferrinIBA 01/2015
1	Vitamin E FDA LinkGeneric 12/2014
1	Lipid NanoparticlesIBA 10/2014
1	AntigensIBA 12/2013
1	Methotrexate (Mexate)FDA LinkGeneric 09/2006
1	guar gum (guaran)IBA 09/2006

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2022 - 04/2013
4	Therapeutics 01/2017 - 01/2015
2	Immunotherapy 08/2015 - 10/2014
1	Injections 01/2022
1	Oral Administration 04/2019
1	Microspheres (Microsphere) 09/2006